NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CME Group Inc.
(NASDAQ:CME), Ambac Financial Group, Inc. (NASDAQ:AMBC), Erie Indemnity Company (NASDAQ:ERIE), FuelCell Energy, Inc. (NASDAQ:FCEL),
Hovnanian Enterprises Inc (NYSE:HOV), and Rexahn Pharmaceuticals, Inc. (NYSE:RNN), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CME DOWNLOAD: http://Fundamental-Markets.com/register/?so=CME
AMBC DOWNLOAD: http://Fundamental-Markets.com/register/?so=AMBC
ERIE DOWNLOAD: http://Fundamental-Markets.com/register/?so=ERIE
FCEL DOWNLOAD: http://Fundamental-Markets.com/register/?so=FCEL
HOV DOWNLOAD: http://Fundamental-Markets.com/register/?so=HOV
RNN DOWNLOAD: http://Fundamental-Markets.com/register/?so=RNN
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine CME
Group Inc. (NASDAQ:CME), Ambac Financial Group, Inc. (NASDAQ:AMBC), Erie Indemnity Company (NASDAQ:ERIE), FuelCell Energy, Inc.
(NASDAQ:FCEL), Hovnanian Enterprises Inc (NYSE:HOV), and Rexahn Pharmaceuticals, Inc. (NYSE:RNN) on a fundamental level and
outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's
readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed December 7th,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CME GROUP INC. (CME) REPORT OVERVIEW
CME Group's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, CME Group reported revenue of $904.20MM
vs $890.80MM (up 1.50%) and analysts estimated basic earnings per share $1.21 vs $0.91 (up 32.97%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, CME Group reported revenue of $3,644.70MM vs $3,595.20MM (up 1.38%) and analysts
estimated basic earnings per share $12.00 vs $4.55 (up 163.74%). Analysts expect earnings to be released on February 7th, 2019. The
report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.12. The
estimated EPS forecast for the next fiscal year is $7.24 and is expected to report on February 7th, 2019.
To read the full CME Group Inc. (CME) report, download it here: http://Fundamental-Markets.com/register/?so=CME
-----------------------------------------
AMBAC FINANCIAL GROUP, INC. (AMBC) REPORT OVERVIEW
Ambac Financial Group's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Ambac Financial Group reported revenue
of $134.02MM vs $133.25MM (up 0.57%) and analysts estimated basic earnings per share -$2.27 vs -$4.20. For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Ambac Financial Group reported revenue of $621.25MM vs $506.15MM (up 22.74%) and
analysts estimated basic earnings per share -$7.25 vs $1.66. Analysts expect earnings to be released on February 27th, 2019. The
report will be for the fiscal period ending December 31st, 2018.
To read the full Ambac Financial Group, Inc. (AMBC) report, download it here: http://Fundamental-Markets.com/register/?so=AMBC
-----------------------------------------
ERIE INDEMNITY COMPANY (ERIE) REPORT OVERVIEW
Erie Indemnity's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Erie Indemnity reported revenue of
$612.13MM vs $442.49MM (up 38.34%) and analysts estimated basic earnings per share $1.74 vs $1.27 (up 37.01%). For the twelve
months ended December 31st, 2017 vs December 31st, 2016, Erie Indemnity reported revenue of $1,691.77MM vs $1,596.63MM (up 5.96%)
and analysts estimated basic earnings per share $4.27 vs $4.55 (down 6.15%). Analysts expect earnings to be released on February
28th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was
$0.80.
To read the full Erie Indemnity Company (ERIE) report, download it here: http://Fundamental-Markets.com/register/?so=ERIE
-----------------------------------------
FUELCELL ENERGY, INC. (FCEL) REPORT OVERVIEW
FuelCell Energy's Recent Financial Performance
For the three months ended July 31st, 2018 vs July 31st, 2017, FuelCell Energy reported revenue of $12.11MM vs
$10.36MM (up 16.91%) and basic earnings per share -$0.20 vs -$0.31. For the twelve months ended October 31st, 2017 vs October 31st,
2016, FuelCell Energy reported revenue of $95.67MM vs $108.25MM (down 11.63%) and analysts estimated basic earnings per share
-$1.14 vs -$1.82. Analysts expect earnings to be released on January 10th, 2019. The report will be for the fiscal period ending
October 31st, 2018. The reported EPS for the same quarter last year was -$0.17. The estimated EPS forecast for the next fiscal year
is -$0.50 and is expected to report on January 10th, 2019.
To read the full FuelCell Energy, Inc. (FCEL) report, download it here: http://Fundamental-Markets.com/register/?so=FCEL
-----------------------------------------
HOVNANIAN ENTERPRISES INC (HOV) REPORT OVERVIEW
Hovnanian Enterprises' Recent Financial Performance
For the three months ended July 31st, 2018 vs July 31st, 2017, Hovnanian Enterprises reported revenue of
$456.71MM vs $592.04MM (down 22.86%) and analysts estimated basic earnings per share -$0.01 vs -$2.28. For the twelve months ended
October 31st, 2017 vs October 31st, 2016, Hovnanian Enterprises reported revenue of $2,451.67MM vs $2,752.25MM (down 10.92%) and
analysts estimated basic earnings per share -$2.25 vs -$0.02. Analysts expect earnings to be released on March 14th, 2019. The
report will be for the fiscal period ending January 31st, 2019.
To read the full Hovnanian Enterprises Inc (HOV) report, download it here: http://Fundamental-Markets.com/register/?so=HOV
-----------------------------------------
REXAHN PHARMACEUTICALS, INC. (RNN) REPORT OVERVIEW
Rexahn Pharmaceuticals' Recent Financial Performance
Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending
December 31st, 2018. The reported EPS for the same quarter last year was -$0.09. The estimated EPS forecast for the next fiscal
year is -$0.52 and is expected to report on March 11th, 2019.
To read the full Rexahn Pharmaceuticals, Inc. (RNN) report, download it here: http://Fundamental-Markets.com/register/?so=RNN
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
